Physician
Boston Pediatrics, PLLC
Boston Pediatrics, PLLC was paid $2.76M by Medicaid between Jan 2018 and Dec 2024, across 111 billing codes. Its largest line is 92587, — 17% of everything it billed.
33Billing provider infoBOSTON PEDIATRICS, PLLC
BRONX, NY 10456
BRONX, NY 10456
33aNPI1275724767assigned 08/08/2007
33bProvider typePediatrics Physician
28Total paid$2.76M
24GClaims672,908
24DCodes billed111
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#123 of 1,983
Median peer was paid$17K
This provider vs. median163×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 78,920 | $848K | |
| 2019 | 94,974 | $607K | |
| 2020 | 93,688 | $260K | |
| 2021 | 112,610 | $382K | |
| 2022 | 83,879 | $207K | |
| 2023 | 111,924 | $243K | |
| 2024incomplete | 96,913 | $213K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92587 | 17% | 33,999 | 33,948 | $470K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 13% | 22,492 | 22,228 | $353K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 9.6% | 32,969 | 32,942 | $266K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.9% | 27,483 | 25,493 | $246K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 5.1% | 6,227 | 6,209 | $141K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4.7% | 10,246 | 10,164 | $129K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.9% | 32,662 | 29,870 | $108K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.3% | 11,281 | 11,268 | $91K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.2% | 10,684 | 10,675 | $88K |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | 2.8% | 46,216 | 44,943 | $77K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.5% | 9,976 | 9,627 | $70K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 2.4% | 24,362 | 24,334 | $65K |
99 more codes
| 0001A | 2.0% | 1,399 | $54K | |
| 99177 | 1.8% | 29,624 | $50K | |
| 0002A | 1.8% | 1,313 | $49K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.8% | 5,686 | $49K |
| 90620 | 1.5% | 3,741 | $40K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.3% | 5,068 | $35K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.3% | 12,448 | $35K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 7,198 | $27K |
| 97802 | <1% | 20,142 | $24K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13,441 | $20K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 14,373 | $19K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,124 | $18K |
| 0071A | <1% | 535 | $18K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,562 | $17K |
| S9451 | Exercise classes, non-physician provider, per session | <1% | 28,943 | $17K |
| 83015 | <1% | 11,246 | $16K | |
| 0072A | <1% | 399 | $15K | |
| 86580 | <1% | 1,968 | $13K | |
| H0001 | Alcohol and/or drug assessment | <1% | 16,353 | $12K |
| 36415 | Collection of venous blood by venipuncture | <1% | 37,963 | $11K |
| 87631 | <1% | 1,476 | $11K | |
| 90686 | <1% | 15,497 | $10K | |
| 0011A | <1% | 229 | $9K | |
| 0003A | <1% | 237 | $9K | |
| 0012A | <1% | 208 | $8K | |
| 99173 | <1% | 1,365 | $6K | |
| 36406 | <1% | 2,270 | $5K | |
| 86480 | <1% | 1,244 | $5K | |
| 90651 | <1% | 3,818 | $5K | |
| 90670 | <1% | 2,343 | $5K | |
| 91307 | <1% | 1,070 | $5K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 575 | $4K |
| 85018 | <1% | 2,218 | $4K | |
| 90734 | <1% | 3,139 | $3K | |
| 0013A | <1% | 77 | $3K | |
| 90716 | <1% | 978 | $3K | |
| 0124A | <1% | 59 | $2K | |
| 94070 | <1% | 113 | $2K | |
| 90707 | <1% | 824 | $2K | |
| 3074F | <1% | 7,786 | $2K | |
| 36410 | <1% | 1,671 | $1K | |
| 90633 | <1% | 2,894 | $1K | |
| D1206 | Topical application of fluoride varnish | <1% | 96 | $1K |
| 99383 | <1% | 114 | $1K | |
| 0154A | <1% | 29 | $1K | |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 16,093 | $1K |
| 90672 | <1% | 433 | $921.18 | |
| 90744 | <1% | 2,057 | $853.13 | |
| 90715 | <1% | 1,367 | $838.38 | |
| 99381 | <1% | 125 | $803.72 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 100 | $798.78 |
| 90723 | <1% | 1,426 | $755.00 | |
| 90685 | <1% | 572 | $537.93 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 131 | $507.19 |
| 3079F | <1% | 1,821 | $460.00 | |
| 91308 | <1% | 13 | $450.02 | |
| 90634 | <1% | 358 | $442.49 | |
| 99382 | <1% | 13 | $283.59 | |
| 87081 | <1% | 1,377 | $272.89 | |
| 90671 | <1% | 909 | $246.20 | |
| 36416 | <1% | 563 | $210.00 | |
| 90700 | <1% | 521 | $115.00 | |
| 90661 | <1% | 887 | $114.43 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 27 | $105.35 |
| 91300 | <1% | 2,716 | $104.00 | |
| 99384 | <1% | 39 | $99.65 | |
| 90680 | <1% | 1,785 | $75.00 | |
| A7016 | Dome and mouthpiece, used with small volume ultrasonic nebulizer | <1% | 109 | $58.26 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 110 | $54.39 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 142 | $30.00 |
| 94760 | <1% | 100 | $16.86 | |
| 90648 | <1% | 2,152 | $11.00 | |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | <1% | 97 | $4.75 |
| G9275 | Documentation that patient is a current non-tobacco user | <1% | 14,032 | $0.70 |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | <1% | 15,864 | $0.52 |
| 91301 | <1% | 405 | $0.48 | |
| G9273 | Blood pressure has a systolic value of < 140 and a diastolic value of < 90 | 0% | 4,633 | $0.00 |
| 1036F | 0% | 11,552 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 13,432 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 1,526 | $0.00 |
| 90696 | 0% | 718 | $0.00 | |
| 3008F | 0% | 1,458 | $0.00 | |
| 1000F | 0% | 213 | $0.00 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 167 | $0.00 |
| G9228 | Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings) | 0% | 654 | $0.00 |
| 90697 | 0% | 131 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 12 | $0.00 |
| 90619 | 0% | 13 | $0.00 | |
| 90698 | 0% | 13 | $0.00 | |
| 3725F | 0% | 11,582 | $0.00 | |
| 3016F | 0% | 11,540 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 10,476 | $0.00 |
| 90710 | 0% | 825 | $0.00 | |
| 1160F | 0% | 2,099 | $0.00 | |
| 3210F | 0% | 548 | $0.00 | |
| G9820 | Documentation of a chlamydia screening test with proper follow-up | 0% | 351 | $0.00 |
| 99499 | 0% | 63 | $0.00 | |
| 90713 | 0% | 13 | $0.00 | |
| 90681 | 0% | 92 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCORNIELLE, JORGE (MEDICAL DOCTOR)
| Provider | Location | Paid |
|---|---|---|
| BRMC Medical PLLC | Bronx, NY | $6.16M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.